ABERRANT IMMUNE LANDSCAPE IN BONE MARROW OF HIGH-RISK MYELODYSPLASTIC SYNDROME PATIENTS

被引：0
|
作者：
Rai, R. [1 ]
Patel, F. [1 ]
Feld, J. [1 ]
Melana, S. [1 ]
Demakos, E. [1 ]
Horowitz, A. [2 ]
Silverman, L. [1 ]
机构：
[1] Tisch Canc Inst, Icahn Sch Med, Hematol Med Oncol, New York, NY USA
[2] Icahn Sch Med, Lipshultz Precis Immunol Inst, Tisch Canc Inst, Dept Oncol Sci, New York, NY USA
来源：
LEUKEMIA RESEARCH | 2023年 / 128卷
关键词：
D O I：
10.1016/j.leukres.2023.107215
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P080
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Treatment of patients with high-risk myelodysplastic syndromes
    Gattermann, Norbert
    Kuendgen, Andrea
    Germing, Ulrich
    CANCER TREATMENT REVIEWS, 2007, 33 : S64 - S68
  • [22] Predictive markers of myelodysplastic syndrome in the bone marrow of patients with inherited bone marrow failure syndromes
    Al-Rahawan, Mohamad M.
    Alter, Blanche P.
    Bryant, Barbara J.
    Elghetany, M. Tarek
    PEDIATRIC BLOOD & CANCER, 2007, 48 (06) : 605 - 605
  • [23] Oxidative DNA damage in bone marrow cells of patients with low-risk myelodysplastic syndrome
    Novotna, Bozena
    Bagryantseva, Yana
    Siskova, Magda
    Neuwirtova, Radana
    LEUKEMIA RESEARCH, 2009, 33 (02) : 340 - 343
  • [24] Reduced expression of FLIPSHORT in bone marrow of low risk myelodysplastic syndrome
    Campos, Paula de Melo
    Traina, Fabiola
    Santos Duarte, Adriana da Silva
    Lorand-Metze, Irene
    Costa, Fernando F.
    Saad, Sara T. O.
    LEUKEMIA RESEARCH, 2007, 31 (06) : 853 - 857
  • [25] Bone Marrow Immune Microenvironment in Myelodysplastic Syndromes
    Kouroukli, Olga
    Symeonidis, Argiris
    Foukas, Periklis
    Maragkou, Myrto-Kalliopi
    Kourea, Eleni P.
    CANCERS, 2022, 14 (22)
  • [26] Aberrant microRNA expression pattern in myelodysplastic bone marrow cells
    Hussein, Kais
    Theophile, Katharina
    Buesche, Guntram
    Schlegelberger, Brigitte
    Goehring, Gudrun
    Kreipe, Hans
    Bock, Oliver
    LEUKEMIA RESEARCH, 2010, 34 (09) : 1169 - 1174
  • [27] SHOULD CYTOREDUCTIVE TREATMENT BE PERFORMED BEFORE TRANSPLANTATION IN PATIENTS WITH HIGH-RISK MYELODYSPLASTIC SYNDROME?
    Della Porta, M. G.
    HAEMATOLOGICA, 2015, 100 : 199 - 200
  • [28] Should Cytoreductive Treatment Be Performed Before Transplantation in Patients With High-Risk Myelodysplastic Syndrome?
    Alessandrino, Emilio Paolo
    Della Porta, Matteo Giovanni
    Pascutto, Cristiana
    Bacigalupo, Andrea
    Rambaldi, Alessandro
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (21) : 2761 - 2762
  • [29] Eltrombopag in patients with high-risk myelodysplastic syndrome or acute myeloid leukaemia: cautious optimism
    Buckstein, Rena
    LANCET HAEMATOLOGY, 2015, 2 (10): : E396 - E397
  • [30] Classical inherited bone marrow failure syndromes with high risk for myelodysplastic syndrome and acute myelogenous leukemia
    Savage, Sharon A.
    Dufour, Carlo
    SEMINARS IN HEMATOLOGY, 2017, 54 (02) : 105 - 114
12345